| Open Document File Size: 46,78 KBShare Result on Facebook
IndustryTerm registry protocols / treatment for localized prostate cancer / healthcare services / autologous active cellular immunotherapy product / / MedicalCondition tumor / strokes / Cancer / chronic myelomonocytic leukemia / disease / secondary hematologic malignancies / Stroke / hematologic malignancies / invasive prostate cancer / localized prostate cancer / independent prostate cancer / secondary hematologic malignancy / refractory prostate cancer / prostate cancer / Sepsis / / MedicalTreatment leukopheresis / prostatectomy / immunotherapy / / Organization FDA / Medicare / / Person Robert Wise / Connell M.D. Ph / Lori Tull / M. Miles Braun / / Position Medical Officer / Director Background OBE/DE MPH Division / Regulatory Project Manager / MPH Branch Chief / Manager OCTGT/CBER Date / / PublishedMedium the OCTGT review / / Technology registry protocols / / URL www.cdc.gov/nchs/ndi.htm / www.fda.gov/cder/guidance/6358fnl.pdf / http /
SocialTag |